Injectable Contraception with Depot Medroxyprogesterone Acetate
- 1 June 1993
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 45 (6) , 857-865
- https://doi.org/10.2165/00003495-199345060-00001
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancerContraception, 1992
- Bone density in women receiving depot medroxyprogesterone acetate for contraception.BMJ, 1991
- Depo Provera: A Profile of Current UsersAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1990
- Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancerJournal of Clinical Epidemiology, 1990
- Depot medroxyprogesterone (Depo-Provera) and risk of breast cancer.BMJ, 1989
- Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraceptionContraception, 1988
- A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection: I. Contraceptive efficacy and side effectsContraception, 1988
- The effects of contraceptive use on the initiation and duration of lactationInternational Journal of Gynecology & Obstetrics, 1987
- Metabolic effects of depot-medroxyprogesterone acetate in long-term users: A cross-sectional studyInternational Journal of Gynecology & Obstetrics, 1986
- Return of fertility after use of the injectable contraceptive Depo Provera: up-dated data analysisJournal of Biosocial Science, 1984